☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
GSK
PharmaShots Weekly Snapshots (April 15 – April 19, 2024)
April 19, 2024
GSK to Highlight Results from the P-III (EAGLE-1) Study of Gepotidacin for Treating Uncomplicated Urogenital Gonorrhoea (GC) at ES...
April 18, 2024
GSK to Feature Results from the P-III (ZOSTER-049) Study of Shingrix for Protection Against Shingles at ESCMID Global 2024
April 17, 2024
The US FDA Accepts GSK’s BLA of Meningococcal ABCWY Vaccine for Invasive Meningococcal Disease (IMD)
April 16, 2024
GSK Highlights the P-III (RUBY) Trial Results of Jemperli to Treat Endometrial Cancer at Society of Gynecologic Oncology 2024
March 18, 2024
GSK Reports P-III (DREAMM-8) Study Results of Blenrep for Treating Relapsed/Refractory Multiple Myeloma (RRMM)
March 7, 2024
Load more...
Back to Home